Hem › Bukspottkörtelcancer › Minnesota › Rochester
Kliniska studier för Bukspottkörtelcancer i Rochester, MN
22 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Rochester (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
RekryterarFas 2
- Mayo Clinic in Rochester, Rochester
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekryterarFas 1
- Mayo Clinic Rochester, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekryterarObservationsstudie
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 3
- Mayo Clinic Cancer Center, Rochester
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekryterarFas 1/2
- Mayo Clinic, Rochester
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
RekryterarObservationsstudie
- Mayo Clinic in Rochester, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 2
- Mayo Clinic Rochester, Rochester
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekryterarFas 2
- Local Institution - 0129, Rochester
- Local Institution - 0174, Rochester
- Local Institution - 0181, Rochester
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
RekryterarFas 2
- Mayo Clinic in Rochester, Rochester
CREO - Microwave Ablation Feasibility Study
Rekryterar
- Mayo Clinic Rochester, Rochester
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- Mayo Clinic in Rochester, Rochester
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekryterarFas 2
- Mayo Clinical Rochester, Rochester
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekryterarFas 1
- Mayo Clinic, Rochester
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
RekryterarFas 2
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekryterarFas 1/2
- Mayo Clinic Rochester, Rochester
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
RekryterarObservationsstudieFriska volontärer välkomna
- Mayo Clinic in Rochester, Rochester
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RekryterarObservationsstudie
- Mayo Clinic in Rochester, Rochester
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekryterarFas 2
- Ohio State University Telemedicine, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekryterarObservationsstudieFriska volontärer välkomna
- Mayo Clinic, Rochester
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
RekryterarFas 1/2
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #14, Rochester
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andra studier i Rochester
- Bröstcancer42 studier
- Icke-småcellig lungcancer37 studier
- Metastaserande cancer31 studier
- Cancer (alla typer)30 studier
- Äggstockscancer29 studier
- Kolorektal cancer29 studier
- Multipelt myelom24 studier
- Hjärtsvikt22 studier
- Prostatacancer22 studier
- Endometriecancer20 studier
- Lungcancer20 studier
- Kronisk lymfatisk leukemi18 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.